Results 251 to 260 of about 49,899 (288)

Abstract Supplement HIV Glasgow 8–11 November 2026, Glasgow, UK/Virtual

open access: yes
Journal of the International AIDS Society, Volume 29, Issue S6, November 2026.
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

The clinical utility of CD163 in viral diseases

Clinica Chimica Acta, 2023
Macrophage activation and hypercytokinemia are notable presentations in certain viral infections leading to severe disease and poor prognosis. Viral infections can cause macrophage polarization into the pro-inflammatory M1 or anti-inflammatory M2 phenotype.
Yap, Yi-Jing   +7 more
openaire   +3 more sources

Biological variation of soluble CD163

Scandinavian Journal of Clinical and Laboratory Investigation, 2003
A soluble plasma form of CD163 (sCD163) was recently identified. The protein has anti-inflammatory effects in vitro and is elevated in patients with myelo-monocytic leukaemia and infection. For rational use and evaluation of this potential new quantity it is important to have knowledge of its biological variability and to use a methodology that has a ...
Møller, Holger Jon   +3 more
openaire   +6 more sources

Soluble CD163

Scandinavian Journal of Clinical and Laboratory Investigation, 2011
CD163 is an endocytic receptor for haptoglobin-hemoglobin complexes and is expressed solely on macrophages and monocytes. As a result of ectodomain shedding, the extracellular portion of CD163 circulates in blood as a soluble protein (sCD163) at 0.7-3.9 mg/l in healthy individuals.
openaire   +3 more sources

Home - About - Disclaimer - Privacy